Piramal Pharma Rights Issue 2023 vs SEPC Rights Issue 2023

Comparison between Piramal Pharma Rights Issue 2023 and SEPC Rights Issue 2023.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Piramal Pharma Rights Issue 2023 and SEPC Rights Issue 2023. Piramal Pharma Rights Issue 2023 is listed on BSE, NSE while SEPC Rights Issue 2023 is listed on BSE, NSE.

 Piramal Pharma LimitedSEPC Limited
LogoPiramal Pharma Rights Issue 2023 LogoSEPC Rights Issue 2023 Logo
Listing AtBSE, NSEBSE, NSE
Terms of PaymentFull Amount on ApplicationFull Amount on Application
Entitlement5 Rights Equity Share(s) for every 46 fully paid-up Equity Shares held on Record Date2 Rights Equity Share(s) for every 53 fully paid-up Equity Shares held on Record Date
Application FormApplication Form Application Form
Letter of Offer Letter of Offer Letter of Offer
RegistrarMUFG Intime India Pvt.Ltd.Cameo Corporate Services Ltd.
Lead ManagersICICI Securities Ltd.

Rights Issue Size and Price

The issue size of Piramal Pharma Rights Issue 2023 rights issue is ₹1,050.00 Crores, whereas SEPC Rights Issue 2023 rights issue size is ₹49.90 Crores.

 Piramal Pharma LimitedSEPC Limited
Issue Size12,96,29,630 shares4,99,00,000 shares
Issue Size (Amount)₹1,050.00 Crores₹49.90 Crores
Issue Price₹81 per share₹10 per share
Face Value₹10 per share₹10 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of Piramal Pharma Rights Issue 2023 is Aug 02, 2023 while record date of SEPC Rights Issue 2023 is Mar 29, 2023.

 Piramal Pharma LimitedSEPC Limited
Record DateAug 02, 2023Mar 29, 2023
Credit of Rights Entitlements
Bid/Offer Opens OnAug 08, 2023Apr 10, 2023
Renunciation of Rights EntitlementsAug 10, 2023Apr 18, 2023
Bid/Offer Closes OnAug 17, 2023Apr 24, 2023
Deemed Date of AllotmentAug 23, 2023May 03, 2023
Credit DateAug 24, 2023May 05, 2023
Listing DateAug 28, 2023May 08, 2023

Financials details

Comparison of Piramal Pharma Rights Issue 2023 and SEPC Rights Issue 2023 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

 Piramal Pharma LimitedSEPC Limited
Financial
Piramal Pharma Rights Issue 2023 Financial Information (Restated Consolidated)
Period Ended31 Mar 202131 Mar 202231 Mar 2023
Assets10,899.7812,797.0414,522.56
Revenue6,479.016,834.907,306.66
Profit After Tax835.03375.96-186.46
Net Worth5,076.756,069.945,968.45
Reserves and Surplus4,488.625,290.695,181.79
Total Borrowing2,910.194,023.285,504.77
Amount in ₹ Crore
SEPC Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After Tax
31-Mar-202,602.651,258.87-77.26
31-Mar-212,416.29606.13-179.47
31-Mar-222,223.22340.59-263.70
Amount in ₹ Crore

Compare with others

Compare: